News

CureVac (CVAC) and GSK (GSK) to receive $740M and other payments in a settlement with Pfizer (PFE) and BioNTech (BNTX) over ...
The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
Gilead Sciences generates stellar profit margins with its HIV and hepatitis C virus, or HCV, portfolio, which requires only a small salesforce and inexpensive manufacturing. We think its portfolio and ...
German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long patent ...
As noted in the first article in our Medtech Coming to America series, “US Emerging as Top Global Medtech Destination,” perceived ...
Hong stated that Netlist had a productive second quarter, emphasizing "we strengthened our cash position, ramped sales of custom DDR4 products, filed new legal actions against Samsung and Micron, ...
Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...
A new patent from Stellantis could give the best of both worlds and potentially maximize range as well as performance based on what the driver demands. The patent, which was issued August 5, has a ...
According to the American Hospital Association, more than 40% of expenses hospitals incur come from administrative costs. This significant burden impacts providers and can even lead to delays in ...
Shelley Thomas didn’t let age stop her from doing something big. She didn’t let legalese, imperfect prototypes or dust stop ...
Customers can access the company's extensive patent portfolio and the BluWave-ai Atlas data platform through product purchases, or directly via an IP usage license for specific applications.